INMED PHARMACEUTICALS INC. Other Cash Equivalents, at Carrying Value
INMED PHARMACEUTICALS INC. (INM) had Other Cash Equivalents, at Carrying Value of $1.96 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Cash and Cash Equivalents
us-gaap:OtherCashEquivalentsAtCarryingValue · last filed 2024-11-14
- 2024-09-30: Other Cash Equivalents, at Carrying Value $1.96M.
- 2024-06-30: Other Cash Equivalents, at Carrying Value $1.94M.
- 2023-06-30: Other Cash Equivalents, at Carrying Value $1.48M.
| Period end | Other Cash Equivalents, at Carrying Value |
|---|---|
| 2024-09-30 | $1.96M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.94M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.48M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |